During the past decade, ThedaCare Cancer Care - New London conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "ThedaCare Cancer Care - New London" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator and "NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "ThedaCare Cancer Care - New London" are "Breast Carcinoma" (1 trials), "Colorectal Adenocarcinoma" (1 trials), "Estrogen Receptor Negative" (1 trials), "HER2/Neu Negative" (1 trials) and "Invasive Breast Carcinoma" (1 trials). Many other conditions were trialed in "ThedaCare Cancer Care - New London" in a lesser frequency.

Most popular intervention types in "ThedaCare Cancer Care - New London" are "Drug" (2 trials), "Other" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Capecitabine" (1 trials), "Carboplatin" (1 trials), "Cholecalciferol" (1 trials) and "Cisplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "ThedaCare Cancer Care - New London" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "ThedaCare Cancer Care - New London". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in ThedaCare Cancer Care - New London, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in ThedaCare Cancer Care - New London, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".